Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

Seekyo S.A.S.

Seekyo is a privately-owned biotech company that develops the next generation of chemotherapies. By targeting the microenvironment of solid tumors while sparing healthy tissues, its aim is to provide efficient treatments without adverse effects to cancer patients. Thanks to its technology, Seekyo’s Smart Drugs are designed to transport potent anticancer agents in an innocuous manner towards safe tissues, recognize specificities of the tumor microenvironment and release the active drug in a stringently controlled fashion following an enzymatic activation. Founded in 2018, the company is based in Poitiers, France. *

 

Period Start 2018-06-15 established
Products Industry BIOTECH
  Industry 2 vector (biotech)
Persons Person Chetboun, Oury (Seekyo 201806– CEO + Co-Founder)
  Person 2 Papot, Sébastian (Univ Poitiers 202001 Prof + Seekyo 201806– CSO + Co-Founder)
     
Region Region Poitiers
  Country France
  Street 4 rue Carol Heinz
  City 86000 Poitiers
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Seekyo S.A.S.. (1/20/20). "Press Release: Biotech Start-up Seekyo Raises €800k with Leverage from French Tech Seed Fund". Poitiers.
     
   
Record changed: 2021-03-19

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Seekyo S.A.S.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top